| Literature DB >> 26513534 |
Orion Z McCotter, Rachel M Smith, Mathew Westercamp, Thomas M Kerkering, Anurag N Malani, Robert Latham, Sheree L Peglow, Rajal K Mody, Peter G Pappas, Tom M Chiller.
Abstract
During September 2012, CDC, in collaboration with state and local health departments and the Food and Drug Administration (FDA), investigated a multistate outbreak of fungal meningitis and other infections caused by injections of contaminated methylprednisolone acetate solution (MPA). After this unprecedented outbreak, scientists in the CDC Mycotic Diseases Branch, along with infectious diseases specialists who cared for patients from the outbreak, clinical experts, and public health officials from affected states, have continued to monitor the recovery of affected patients. A long-term follow-up study involving these patients was initiated and is being conducted by the Mycoses Study Group Education and Research Consortium (MSGERC). This update summarizes subsequent information about the current state of the outbreak.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26513534 DOI: 10.15585/mmwr.mm6442a4
Source DB: PubMed Journal: MMWR Morb Mortal Wkly Rep ISSN: 0149-2195 Impact factor: 17.586